Sign in

NCT06675500CompletedPhase 3

Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery

Source: ClinicalTrials.gov · Last updated 17 Aug 2025

Brief summary (registry, in English)

Atrial fibrillation (AF) is a common complication after cardiac surgery. Most studies suggest that the frequency ranges between 25-40%. Some studies have shown that serum hypomagnesaemia is common after coronary artery bypass grafts (CABG) and other types of cardiac surgery and is associated with postoperative morbidity such as atrial tachyarrhythmia. The aim of the present study is to investigate the anti-arrhythmic effect of Magnesium Sulfate in prevention of atrial fibrillation post cardiac surgery.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
130 (actual)
First submitted
4 Nov 2024
Start date
1 Nov 2024
Primary completion date
15 Apr 2025
Lead sponsor
Ain Shams University
NCT number
NCT06675500

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 130
  • From 1 Nov 2024 to the primary completion date, 15 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Emergency open heart surgeries
  • Patients with Chronic Kidney disease, Renal failure on dialysis

Lab values

  • Patients with preoperative serum creatinine level ≥ 1.8 mg/dL

Other

  • Patients refuse to give informed consent.
  • Redo cases.
  • Patients with reduced intra/post operative urine output ≤ 1 ml/kg/hour.
  • Patients with rhythm defects as proved by ECG before administration of Mg/Placebo.

Who the study is looking for

  • • Elective open heart surgeries for coronary bypass grafting CABG,valvular lesion single or multiple replacement, combined CABG and valvular; with EF in preoperative echo is more than or equal 40%

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine-Ain Shams University
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.